PLASMAFLO OP OP-05W

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign report with the FDA on 2016-04-27 for PLASMAFLO OP OP-05W manufactured by Asahi Kasei Medical Co., Ltd..

Event Text Entries

[43712958] The product in complaint was not returned to the manufacturer and could not be analyzed. The lot number in complaint was not reported and we could not review the manufacturing and quality control records. Hypotension is listed in ifu as the event to monitor during the treatment. This ae might occurred in part or in total related to the patient's physiology. Plasmaflo op is used as plasma separator and immusorba ph is used for immunoadsorption column for separated plasma. This incident occurred in (b)(6) and is reported to fda according to the requirement.
Patient Sequence No: 1, Text Type: N, H10


[43712959] The female patient experienced the following adverse event in (b)(6). (b)(6) 2016 10:20 the patient was started the treatment of the immunoadsorption plasmapheresis (iapp) with the plasma separator (plasmaflo op). After 15 minutes the treatment started, her blood pressure decreased from 123 mmhg to 60 mmhg. The treatment of iapp was stopped, and she was given the treatment with the normal saline solution 150ml intravenously. She was treated with the solu-cortef injection (1 ampule), then her blood pressure recovered to 130mmhg. After 15 minutes from the discontinuation of the treatment, the treatment of iapp was restarted again, then her blood pressure decreased from 130mmhg to 60mmhg. The treatment of iapp was stopped, and then the patient restarted the treatment of iapp along with an ampule (20ml) of nor-adrenalin injection at a dose of 2 ml/hr. Her blood pressure became stable. The plasma flow rate was changed from 20 ml/min to 15ml/min. Afterward her blood pressure remained around 90 mmhg during the treatment, up to the 2000 ml of plasma was treated. 13:10 her treatment was finished, her blood returned, and she left the treatment room.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8010002-2016-00020
MDR Report Key5610788
Report SourceFOREIGN
Date Received2016-04-27
Date of Report2016-03-07
Date of Event2016-03-01
Date Mfgr Received2016-03-07
Date Added to Maude2016-04-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDR. KAORU FURUYA
Manufacturer Street1-105, KANDA, JINBOCHO, CHIYODA-KU,
Manufacturer CityTOKYO, 101-8101
Manufacturer CountryJA
Manufacturer Postal101-8101
Manufacturer G1ASAHI KASEI MEDICAL MT CORP.
Manufacturer Street2111-2 OAZA SATO,
Manufacturer CityOITA, OITA PREFECTURE 870-0396
Manufacturer CountryJA
Manufacturer Postal Code870-0396
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePLASMAFLO OP
Generic NamePLASMA SEPARATOR
Product CodeMDP
Date Received2016-04-27
Model NumberPLASMAFLO OP
Catalog NumberOP-05W
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerASAHI KASEI MEDICAL CO., LTD.
Manufacturer Address1-105, KANDA, JINBOCHO, CHIYODA-KU, TOKYO, 101-8101 JA 101-8101


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2016-04-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.